Share

Analyst on what Biogen's Alzheimer's drug means for the company

Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss what FDA approval for Biogen's Alzheimer's drug means for the future of the company.
02:33
Mon, Jun 7 20213:01 PM EDT